The math on prescription weight loss medications is brutal.

Brand-name Wegovy: $1,300 per month. That's $15,600 annually.

Most insurance won't cover it, and even when they do, copays can hit $500-1,000 monthly.

That's why telehealth companies offering compounded semaglutide (the same active ingredient) for $179-299/month have exploded in popularity.

See MEDVi's Pricing and Program Details

Here's what you need to know: Compounded versions are NOT FDA-approved and haven't undergone the same testing as brand-name drugs.

Quality control standards differ. Real-world results show 2-5% average weight loss (vs. 15% in clinical trials with intensive support).

But for many women, it's the only financially realistic option for accessing medical weight loss treatment.

MEDVi offers:

Find Out if MEDVi is Right for You

This isn't the same as brand-name Wegovy.

But it's legitimate medical supervision at a price point that's actually accessible... $3,588/year vs $15,600/year.

If cost has been the barrier keeping you from exploring medical weight loss, this might be worth a conversation with a licensed physician.

Learn More About Your Options

^{This email contains affiliate links. If you choose to explore any products through our links, we may earn a commission at no additional cost to you. This helps support our free newsletter. Consult your doctor before starting any weight loss medication. The content presented in this email newsletter is for informational purposes only and does not constitute medical advice. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. The information provided in this newsletter is based on sources that we believe to be accurate and reliable. However, we cannot guarantee the accuracy, completeness, timeliness, or usefulness of any information contained in this newsletter.}